Sign in

CIK 0001048477

  • Large accelerated filer

BIOMARIN PHARMACEUTICAL INC

Sign in to watch
Ticker
BMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680397820
Phone
+1 415-506-6700
Business address
105 DIGITAL DRIVE, NOVATO, CA, 94949
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,163,748
in 1 filing

Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Davis George Eric −$1.2M EVP, Chief Legal Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-28 FUCHS HENRY J President, Worldwide R&D Grant or award +36,440 180,534
2023-02-28 FUCHS HENRY J President, Worldwide R&D Grant or award +18,220 198,754
2023-02-28 FUCHS HENRY J President, Worldwide R&D Grant or award +13,392 212,146
2023-02-28 BIENAIME JEAN JACQUES Chief Executive Officer Grant or award +89,700 410,024
2023-02-28 BIENAIME JEAN JACQUES Chief Executive Officer Grant or award +44,860 454,884
2023-02-28 BIENAIME JEAN JACQUES Chief Executive Officer Grant or award +32,972 487,856
2023-02-24 Davis George Eric EVP, Chief Legal Officer Exercise or conversion +1,474 $67.81 $100K 56,725
2023-02-24 Davis George Eric EVP, Chief Legal Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −1,474 0
2023-02-13 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +6,000 $67.81 $407K 326,324
2023-02-13 BIENAIME JEAN JACQUES Chief Executive Officer Sale −6,000 $109.15 $655K 320,324
2023-02-10 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion +15,000 $67.81 $1.0M 335,324
2023-02-10 BIENAIME JEAN JACQUES Chief Executive Officer Sale −15,000 $110.11 $1.7M 320,324
2023-02-10 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −15,000 178,130
2023-02-10 BIENAIME JEAN JACQUES Chief Executive Officer Exercise or conversion · Stock Option (Right to buy Common Stock) −6,000 172,130
2023-02-07 BIENAIME JEAN JACQUES Chief Executive Officer Gift −200 247,333
2023-02-07 BIENAIME JEAN JACQUES Chief Executive Officer Gift +100 100
2023-02-07 BIENAIME JEAN JACQUES Chief Executive Officer Gift +100 100
2023-01-25 Ajer Jeffrey Robert EVP, Chief Commercial Officer Exercise or conversion +49,000 $67.81 $3.3M 90,088
2023-01-25 Ajer Jeffrey Robert EVP, Chief Commercial Officer Sale −44,825 $115.65 $5.2M 45,263
2023-01-25 Ajer Jeffrey Robert EVP, Chief Commercial Officer Sale −4,175 $116.15 $485K 41,088

Page 18 of 23 · 450 trades